|
2010 Journal Article Community pharmacy dispensing of prescription medicine sample packs: Changing the business of medicine initiation?Kyle, GJ, Nissen, L and Tett, S (2010). Community pharmacy dispensing of prescription medicine sample packs: Changing the business of medicine initiation?. Journal of Evaluation in Clinical Practice, 16 (6), 1357-1360. doi: 10.1111/j.1365-2753.2009.01290.x |
|
2010 Journal Article Improving the use of benzodiazepines-Is it possible? A non-systematic review of interventions tried in the last 20 yearsSmith, Alisha J. and Tett, Susan E. (2010). Improving the use of benzodiazepines-Is it possible? A non-systematic review of interventions tried in the last 20 years. BMC Health Services Research, 10 (1) 321, 321-1-321-12. doi: 10.1186/1472-6963-10-321 |
|
2010 Journal Article The contribution of injecting drug users in Sydney, Melbourne and Brisbane to rising benzodiazepine use in Australia 2000 to 2006Smith, A, Tett, S and Hall, W (2010). The contribution of injecting drug users in Sydney, Melbourne and Brisbane to rising benzodiazepine use in Australia 2000 to 2006. Australian And New Zealand Journal of Public Health, 34 (3), 315-319. doi: 10.1111/j.1753-6405.2010.00533.x |
|
2010 Journal Article Towards concordance in healthcare: Perspectives of general practitioners, complementary and alternative medicine practitioners and pharmacists in AustraliaFejzic, J., Emmerton, L. and Tett, S. E. (2010). Towards concordance in healthcare: Perspectives of general practitioners, complementary and alternative medicine practitioners and pharmacists in Australia. Journal of Clinical Pharmacy and Therapeutics, 35 (3), 309-321. doi: 10.1111/j.1365-2710.2009.01093.x |
|
2010 Journal Article An intervention to improve benzodiazepine use-a new approachSmith, Alesha and Tett, Susan E. (2010). An intervention to improve benzodiazepine use-a new approach. Family Practice, 27 (3), 320-327. doi: 10.1093/fampra/cmq007 |
|
2010 Journal Article Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part IIStaatz, Christine E., Goodman, Lucy K. and Tett, Susan E. (2010). Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part II. Clinical Pharmacokinetics, 49 (4), 207-221. doi: 10.2165/11317550-000000000-00000 |
|
2010 Journal Article Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantationKuypers, Dirk R. J., Le Meur, Yannick, Cantarovich, Marcel, Tredger, Michael J., Tett, Susan E., Cattaneo, Dario, Tonshoff, Burkhard, Holt, David W., Chapman, Jeremy, van Gelder, Teun, for The Transplantation Society (TTS) Consensus Group on TDM of MPA and Staatz, Christine E. (2010). Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation. Clinical Journal of the American Society of Nephrology, 5 (2), 341-358. doi: 10.2215/CJN.07111009 |
|
2010 Journal Article Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part IStaatz, Christine E., Goodman, Lucy K. and Tett, Susan E. (2010). Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I. Clinical Pharmacokinetics, 49 (3), 141-175. doi: 10.2165/11317350-000000000-00000 |
|
2009 Journal Article The Queensland experience of participation in a national drug use evaluation project - Community-Acquired Pneumonia-Towards Improving Outcomes Nationally (CAPTION)Pulver, Lisa K., Tett, Susan E. and Coombes, Judith (2009). The Queensland experience of participation in a national drug use evaluation project - Community-Acquired Pneumonia-Towards Improving Outcomes Nationally (CAPTION). BMC Pulmonary Medicine, 9 (1) 38, 1-6. doi: 10.1186/1471-2466-9-38 |
|
2009 Journal Article Comparison of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 (COX-2)inhibitors use in Australia and Nova Scotia (Canada)Barozzi, Nadia, Sketris, Ingrid, Cooke, Charmaine and Tett, Susan (2009). Comparison of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 (COX-2)inhibitors use in Australia and Nova Scotia (Canada). British Journal of Clinical Pharmacology, 68 (1), 106-115. doi: 10.1111/j.1365-2125.2009.03410.x |
|
2009 Journal Article A comparison of mycophenolate use in Australia and Northern Europe, and the impact on the pharmaceutical benefits schemeStaatz, Christine E., Smith, Alesha J. and Tett, Susan E. (2009). A comparison of mycophenolate use in Australia and Northern Europe, and the impact on the pharmaceutical benefits scheme. Pharmacoepidemiology and drug safety, 18 (5), 386-392. doi: 10.1002/pds.1726 |
|
2009 Journal Article How Do Different Age Groups Use Benzodiazepines and Antidepressants?: Analysis of an Australian Administrative Database, 2003–6Smith, Alesha and Tett, Sue E. (2009). How Do Different Age Groups Use Benzodiazepines and Antidepressants?: Analysis of an Australian Administrative Database, 2003–6. Drugs & Aging, 26 (2), 113-122. doi: 10.2165/0002512-200926020-00003 |
|
2009 Journal Article Systematic review of interventions to improve prescribingOstini, Remo, Hegney, Desley, Jackson, Claire, Williamson, Margaret, Mackson, Judith M., Gurman, Karin, Hall, Wayne and Tett, Susan E. (2009). Systematic review of interventions to improve prescribing. The Annals of Pharmacotherapy, 43 (3), 502-513. doi: 10.1345/aph.1L488 |
|
2009 Journal Article Perceived barriers to paracetamol (acetaminophen)prescribing, especially following rofecoxib withdrawal from the marketBarozzi, N. and Tett, S. E. (2009). Perceived barriers to paracetamol (acetaminophen)prescribing, especially following rofecoxib withdrawal from the market. Clinical Rheumatology, 28 (5), 509-519. doi: 10.1007/s10067-008-1077-8 |
|
2008 Journal Article Pharmaceutical company influences on medication prescribing and their potential impact on quality use of medicinesKyle, G. J., Nissen, L. M. and Tett, S. E. (2008). Pharmaceutical company influences on medication prescribing and their potential impact on quality use of medicines. Journal of Clinical Pharmacy and Therapeutics, 33 (5), 553-559. doi: 10.1111/j.1365-2710.2008.00948.x |
|
2008 Journal Article Non-steroidal anti-inflammatory drugs, Cyclooxygenase-2 inhibitors and paracetamol use in Queensland and in the whole of AustraliaBarozzi, Nardia and Tett, Susan E. (2008). Non-steroidal anti-inflammatory drugs, Cyclooxygenase-2 inhibitors and paracetamol use in Queensland and in the whole of Australia. BMC Health Services Research, 8 (Article Number: 196) 196, 196-1-196-9. doi: 10.1186/1472-6963-8-196 |
|
2008 Journal Article A comparison of antidepressant use in Nova Scotia, Canada and AustraliaSmith, Alesha J., Sketris, Ingrid, Cook, Charmaine, Gardner, David, Kisely, Steve and Tett, Susan E. (2008). A comparison of antidepressant use in Nova Scotia, Canada and Australia. Pharmacoepidemiology and Drug Safety, 17 (7), 697-706. doi: 10.1002/pds.1541 |
|
2008 Journal Article Clinical pharmacology: Opportunities for educating new practitioners: An Australian perspectiveTett, S. E. (2008). Clinical pharmacology: Opportunities for educating new practitioners: An Australian perspective. Clinical Pharmacology & Therapeutics, 83 (6), 921-924. doi: 10.1038/clpt.2008.49 |
|
2008 Journal Article Perception of prescription medicine sample packs among Australian professional, government, industry, and consumer organizations, based on automated textual analysis of one-on-one interviewsKyle, G. J., Nissen, L. M. and Tett, S. E. (2008). Perception of prescription medicine sample packs among Australian professional, government, industry, and consumer organizations, based on automated textual analysis of one-on-one interviews. Clinical Therapeutics, 30 (12), 2461-2473. doi: 10.1016/j.clinthera.2008.12.016 |
|
2008 Journal Article Development of a sufficient design for estimation of fluconazole pharmacokinetics in people with HIV infectionRoos, J. F., Kirkpatrick, C. M. J., Tett, S. E., MaLachlan, A. J. and Duffull, S. B. (2008). Development of a sufficient design for estimation of fluconazole pharmacokinetics in people with HIV infection. British Journal of Clinical Pharmacology, 66 (4), 455-466. doi: 10.1111/j.1365-2125.2008.03247.x |
